Jupiter Life Line Hospitals Limited (NSE:JLHL)
India
· Delayed Price · Currency is INR 1,450.00
+27.40 (1.93%)
May 22, 2025, 3:30 PM IST
NSE:JLHL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 12,615 | 10,695 | 8,925 | 7,331 | 4,862 | Upgrade
|
| Other Revenue | - | 10.54 | 3.56 | 40.21 | 41.06 | Upgrade
|
| Revenue | 12,615 | 10,706 | 8,929 | 7,371 | 4,903 | Upgrade
|
| Revenue Growth (YoY) | 17.84% | 19.90% | 21.13% | 50.36% | 5.90% | Upgrade
|
| Cost of Revenue | 4,447 | 4,022 | 3,317 | 2,922 | 2,138 | Upgrade
|
| Gross Profit | 8,169 | 6,683 | 5,612 | 4,450 | 2,764 | Upgrade
|
| Selling, General & Admin | 3,121 | 2,721 | 2,214 | 45.76 | 9.85 | Upgrade
|
| Other Operating Expenses | 2,082 | 1,563 | 1,377 | 2,830 | 2,042 | Upgrade
|
| Operating Expenses | 5,773 | 4,708 | 3,976 | 3,237 | 2,359 | Upgrade
|
| Operating Income | 2,396 | 1,975 | 1,636 | 1,213 | 405.31 | Upgrade
|
| Interest Expense | -105.54 | -226.61 | -387.43 | -366.55 | -314.63 | Upgrade
|
| Interest & Investment Income | - | 194.02 | 68.14 | - | - | Upgrade
|
| Earnings From Equity Investments | - | 31.7 | 20.72 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 286.75 | -20.2 | -29.82 | -72.82 | -75.13 | Upgrade
|
| EBT Excluding Unusual Items | 2,577 | 1,954 | 1,308 | 773.16 | 15.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.03 | 1.61 | - | - | Upgrade
|
| Other Unusual Items | - | - | -22.04 | -1.98 | - | Upgrade
|
| Pretax Income | 2,577 | 1,954 | 1,287 | 771.18 | 15.55 | Upgrade
|
| Income Tax Expense | 642.01 | 188.03 | 558.03 | 259.9 | 38.52 | Upgrade
|
| Earnings From Continuing Operations | 1,935 | 1,766 | 729.05 | 511.28 | -22.97 | Upgrade
|
| Minority Interest in Earnings | -3.03 | - | - | - | - | Upgrade
|
| Net Income | 1,932 | 1,766 | 729.05 | 511.28 | -22.97 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | -45.35 | Upgrade
|
| Net Income to Common | 1,932 | 1,766 | 729.05 | 511.28 | 22.38 | Upgrade
|
| Net Income Growth | 9.39% | 142.25% | 42.59% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 66 | 62 | 52 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 62 | 57 | 53 | 51 | Upgrade
|
| Shares Change (YoY) | 6.48% | 8.94% | 6.67% | 4.16% | -0.00% | Upgrade
|
| EPS (Basic) | 29.47 | 28.68 | 13.91 | 10.05 | 0.44 | Upgrade
|
| EPS (Diluted) | 29.47 | 28.68 | 12.95 | 9.65 | 0.44 | Upgrade
|
| EPS Growth | 2.74% | 121.50% | 34.20% | 2093.19% | -92.44% | Upgrade
|
| Free Cash Flow | -674.22 | 292.26 | 399.24 | 452.4 | -1,182 | Upgrade
|
| Free Cash Flow Per Share | -10.28 | 4.75 | 7.06 | 8.54 | -23.23 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | - | - | - | Upgrade
|
| Gross Margin | 64.75% | 62.43% | 62.86% | 60.36% | 56.38% | Upgrade
|
| Operating Margin | 18.99% | 18.45% | 18.32% | 16.45% | 8.27% | Upgrade
|
| Profit Margin | 15.31% | 16.50% | 8.16% | 6.94% | 0.46% | Upgrade
|
| Free Cash Flow Margin | -5.34% | 2.73% | 4.47% | 6.14% | -24.11% | Upgrade
|
| EBITDA | 2,966 | 2,396 | 2,019 | 1,572 | 711.11 | Upgrade
|
| EBITDA Margin | 23.51% | 22.38% | 22.61% | 21.33% | 14.51% | Upgrade
|
| D&A For EBITDA | 569.84 | 420.79 | 383.01 | 359.48 | 305.81 | Upgrade
|
| EBIT | 2,396 | 1,975 | 1,636 | 1,213 | 405.31 | Upgrade
|
| EBIT Margin | 18.99% | 18.45% | 18.32% | 16.45% | 8.27% | Upgrade
|
| Effective Tax Rate | 24.91% | 9.62% | 43.36% | 33.70% | 247.75% | Upgrade
|
| Revenue as Reported | 12,902 | 10,955 | 9,030 | 7,371 | 4,903 | Upgrade
|
| Advertising Expenses | - | 7.53 | 35.32 | 45.76 | 9.85 | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.